Selected article for: "acute syndrome and lung target"
Author: Fani, Mona; Teimoori, Ali; Ghafari, Shokouh
Title: Comparison of the COVID-2019 (SARS-CoV-2) pathogenesis with SARS-CoV and MERS-CoV infections
  • Cord-id: ncl2p7kg
  • Document date: 2020_5_20
    • ID: ncl2p7kg
    Snippet: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was first identified in several patients who traveled to Wuhan or went to a seafood wholesale market in Wuhan. The phylogenetic tree showed that SARS-CoV-2 was 96.2% identical to bat β-coronaviruses from lineage B. Also, several studies reported that SARS-CoV-2 uses the SARS-CoV receptor, angiotensin-converting enzyme 2, for entry to target cells. Lung alveolar and small intestine are potential targets for SARS-CoV-2 due to the h
    Document: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was first identified in several patients who traveled to Wuhan or went to a seafood wholesale market in Wuhan. The phylogenetic tree showed that SARS-CoV-2 was 96.2% identical to bat β-coronaviruses from lineage B. Also, several studies reported that SARS-CoV-2 uses the SARS-CoV receptor, angiotensin-converting enzyme 2, for entry to target cells. Lung alveolar and small intestine are potential targets for SARS-CoV-2 due to the high expression of the angiotensin-converting enzyme 2 receptor. In this review, we focused on the zoonotic β-coronaviruses and given there is no specific drug or vaccine for coronavirus disease 2019, we reviewed the literature on the therapy options for SARS and Middle East respiratory syndrome coronavirus infection, in order to discover their possible use in the treatment of SARS-CoV-2 infections.

    Search related documents:
    Co phrase search for related documents
    • active immune system and acute respiratory syndrome coronavirus infection: 1
    • acute heart damage and liver heart: 1, 2, 3
    • acute lung failure and liver heart: 1, 2, 3
    • acute lung failure and liver heart kidney: 1
    • acute lung failure and lung alveolar damage: 1
    • acute lung failure and lung epithelial cell: 1
    • acute respiratory distress syndrome and liver cell: 1, 2, 3, 4, 5, 6, 7
    • acute respiratory distress syndrome and liver cell kidney: 1, 2, 3, 4
    • acute respiratory distress syndrome and liver cell kidney lung: 1, 2
    • acute respiratory distress syndrome and liver heart: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory distress syndrome and liver heart kidney: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
    • acute respiratory distress syndrome and low severity: 1, 2, 3, 4, 5, 6, 7
    • acute respiratory distress syndrome and lung alveolar damage: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory distress syndrome and lung epithelial cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • acute respiratory syndrome coronavirus infection and liver heart kidney: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • acute respiratory syndrome coronavirus infection and low severity: 1, 2, 3, 4
    • acute respiratory syndrome coronavirus infection and low susceptibility: 1, 2, 3, 4
    • acute respiratory syndrome coronavirus infection and lung alveolar damage: 1, 2, 3, 4, 5
    • acute respiratory syndrome coronavirus infection and lung epithelial cell: 1, 2, 3, 4, 5, 6, 7